| Mrs Margaret Aikins Keup, APNP | |
|
975 Port Washington Rd, Grafton, WI 53024-9201 | |
| (262) 329-1000 | |
| Not Available |
| Full Name | Mrs Margaret Aikins Keup |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 975 Port Washington Rd, Grafton, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023417169 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greater Milwaukee Critical Care And Pulmonary Associates Sc | 0244304558 | 8 |
| Midwest Critical Care Sc | 4486026804 | 29 |
News Archive
The aim of this unique research consortium is to grasp the whole organ and its functions in a computer model
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.
The current issue of Science magazine features a special section that explores issues surrounding population growth, "many of which continue to split demographers," according to the section's introduction.
› Verified 9 days ago
| Entity Name | Prohealth Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356322440 PECOS PAC ID: 3476465188 Enrollment ID: O20031103000066 |
News Archive
The aim of this unique research consortium is to grasp the whole organ and its functions in a computer model
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.
The current issue of Science magazine features a special section that explores issues surrounding population growth, "many of which continue to split demographers," according to the section's introduction.
› Verified 9 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
The aim of this unique research consortium is to grasp the whole organ and its functions in a computer model
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.
The current issue of Science magazine features a special section that explores issues surrounding population growth, "many of which continue to split demographers," according to the section's introduction.
› Verified 9 days ago
| Entity Name | Greater Milwaukee Critical Care And Pulmonary Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952569816 PECOS PAC ID: 0244304558 Enrollment ID: O20080805000542 |
News Archive
The aim of this unique research consortium is to grasp the whole organ and its functions in a computer model
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.
The current issue of Science magazine features a special section that explores issues surrounding population growth, "many of which continue to split demographers," according to the section's introduction.
› Verified 9 days ago
| Entity Name | Midwest Critical Care Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093425647 PECOS PAC ID: 4486026804 Enrollment ID: O20230214000166 |
News Archive
The aim of this unique research consortium is to grasp the whole organ and its functions in a computer model
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.
The current issue of Science magazine features a special section that explores issues surrounding population growth, "many of which continue to split demographers," according to the section's introduction.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Margaret Aikins Keup, APNP 975 Port Washington Rd, Grafton, WI 53024-9201 Ph: (262) 329-1000 | Mrs Margaret Aikins Keup, APNP 975 Port Washington Rd, Grafton, WI 53024-9201 Ph: (262) 329-1000 |
News Archive
The aim of this unique research consortium is to grasp the whole organ and its functions in a computer model
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.
The current issue of Science magazine features a special section that explores issues surrounding population growth, "many of which continue to split demographers," according to the section's introduction.
› Verified 9 days ago
Mrs. Rachel Emily Rejniak, AGPCNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1615 Willow Ct, Grafton, WI 53024 Phone: 262-365-3008 | |
Rebekah L Otte, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-8150 | |
Bonita J. Wendel, APNP/BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2061 Cheyenne Ct, Grafton, WI 53024 Phone: 262-376-1934 | |
Patricia G Wilhelme, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 Fax: 262-329-1001 | |
Jennifer A Krueger, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-8600 | |
Jill M Mitchell, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 |